Arylsulfonamide derivatives
US7393873B2 · kind B2 · utility
19Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2004 |
| Grant date | Jul 1, 2008 |
| Priority date | — |
| Expiry date | Dec 13, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
N-aryl arylsulfonamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.